Low expression levels of five purine metabolism‐related genes—ADSL, APRT, ADCY3, NME3, and NME6—were associated with worse prognosis in CRC patient subgroups, including wild‐type TP53, mutant TP53, and microsatellite‐stable phenotypes. This evidence concerns the gene ADCY3 and colorectal carcinoma.